IP Library Granted Patent US 7,306,802
Granted Patent B2
US 7,306,802 · App. 11/757,502 · Granted Dec 11, 2007

Ophthalmic compositions containing a synergistic combination of three polymers

Assignee: Alcon, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,306,802
App. No.
11/757,502
Granted
Dec 11, 2007
Kind
B2
Abstract

Ophthalmic compositions suitable for use as artificial tears or as vehicles for ophthalmic drugs are disclosed. The compositions contain a combination of three polymers that have a synergistic effect on viscosity.

Claims (9)

1. An aqueous composition suitable for topical ophthalmic administration comprising three polymeric ingredients having a synergistic effect on the composition's viscosity wherein the three polymeric ingredients are hydroxypropyl methylcellulose and a combination of two polymers selected from the group of combinations consisting of guar gum and a carboxyvinyl polymer; guar gum and hydroxyethyl cellulose; guar gum and dextran; hydroxyethyl cellulose and a carboxyvinyl polymer; and dextran and a carboxyvinyl polymer, provided that if the composition comprises a carboxyvinyl polymer then the composition does not contain sodium chloride or boric acid, wherein the total concentration of the three polymeric ingredients ranges from 0.1-1% (w/v).

2. The composition of claim 1 wherein the guar gum ingredient is hydroxypropyl guar.

3. The composition of claim 1 wherein the carboxyvinyl polymer is a polymer of acrylic acid crosslinked with allyl sucrose or allylpentaerythritol.

4. The composition of claim 1 wherein the total concentration of the three polymeric ingredients ranges from 0.3-0.9% (w/v).

5. The composition of claim 4 wherein the total concentration of the three polymeric ingredients ranges from 0.4-0.7% (w/v).

6. The composition of claim 1 further comprising an ingredient selected from the group consisting of pharmaceutically acceptable buffering agents; preservatives; non-ionic tonicity-adjusting agents; surfactants; solubilizing agents; stabilizing agents; comfort-enhancing agents; emollients; pH-adjusting agents; and lubricants.

7. The composition of claim 1 further comprising an ophthalmic drug.

8. The composition of claim 7 wherein the ophthalmic drug is selected from the group consisting of anti-glaucoma agents; anti-angiogenesis agents; anti-infective agents; non-steroidal and steroidal anti-inflammatory agents; growth factors; immunosuppressant agents; and anti-allergic agents.

9. An aqueous composition for use as an artificial tear wherein the composition consists essentially of hydroxypropyl methylcellulose; a carboxyvinyl polymer; hydroxypropyl guar; and mannitol, wherein the total concentration of the three polymeric ingredients ranges from 0.1-1% (w/v) and the composition has a pH of 6.5-7.5 and an osmolality in the range of 235-260 mOsm/kg.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2016
From: NOVARTIS AG
To: ALCON RESEARCH, LTD
Reel/Frame 040670/0679 →
MERGER Recorded May 31, 2011
From: ALCON, INC.
To: NOVARTIS AG
Reel/Frame 026376/0076 →
Continuity (3)
Division 1086317200 · Jun 8, 2004
Provisional Application 6047871300 · Jun 13, 2003
Related Publication 20070224159A1 · Sep 27, 2007